Want to live to 100? Skip the gym, this daily habit matters more; longevity expert reveals
What if the secret to a longer, healthier life wasn't tucked away in a gym, but instead hiding in plain sight—right in your daily routine? According to leading longevity researcher Dr. Gareth Nye, a long life isn't just about clean genes or killer workouts. It's about what you do
between
the workouts that counts.
The Surprising Power of Everyday Movement
Dr. Nye, a biomedical expert, challenges the age-old belief that intense exercise is the golden ticket to longevity. Instead, he champions what he calls 'whole activity levels'—a fancy way of saying
keep moving throughout the day
. Sitting for hours at a desk, even if balanced with a daily gym session, may still be putting your health at risk.
'People who live longer tend to have a higher activity level in their day-to-day lives, rather than relying on structured exercise programs,' Dr. Nye explained while talking to
The Mirror
. 'It's about avoiding prolonged periods of sitting and making your entire day more dynamic.'
This could mean taking walking breaks between tasks, using a standing desk, or even tweaking your commute to sneak in more steps. The goal? Make movement second nature.
A Sitting Threat You Can't Outrun
Recent studies back this idea, showing that extended periods of inactivity—regardless of how much you work out—can increase the risk of serious health conditions, including Alzheimer's. In essence, your body doesn't forgive long stretches of stillness, even if you're clocking an hour on the treadmill later.
You Might Also Like:
What is a 'sedentary lifestyle'? Cardiologist warns that too much sitting may be as harmful as smoking
The problem with high-intensity workouts, Dr. Nye points out, is sustainability. Many people struggle to stick to them long term, while simply staying active throughout the day is a more realistic, beneficial approach.
Rethink What's on Your Plate
Physical movement is only part of the story. Dr. Nye emphasizes a return to natural, minimally
processed foods
. He warns against a diet high in saturated fats, salt, and sugar, and flags processed meats like bacon and ham as significant threats due to their link to bowel cancer.
'The less processing, the better,' he says. 'Free-range or organic meat and vegetables are ideal. The more processing involved, the more detrimental it is to the body.'
Even for those on a tight schedule or budget, he recommends frozen fruits and vegetables as a practical alternative to fresh produce. 'They're just as beneficial and often easier to add into meals,' he adds.
You Might Also Like:
Why you keep waking up at 3 a.m.? The hidden sleep crisis millions are Googling right now
Sleep: Your Nighttime Lifeline
If there's one thing you can't afford to skimp on, it's sleep. According to Dr. Nye, getting less than seven hours a night increases your risk of death by 12 percent. But don't oversleep either—those regularly clocking more than eight hours face an even higher 30 percent risk.
'Regular sleep patterns are key,' he stresses. 'They help regulate the body's internal systems, which in turn can impact how long you live.'
Lack of quality sleep has been linked to obesity, heart disease, and Type 2 diabetes, all of which can chip away at life expectancy.
Know Thyself—And Your Family
Finally, Dr. Nye underscores the role of genetics in lifespan. While only 20 to 30 percent of longevity is influenced by DNA, knowing your family history can offer crucial insight into potential health risks.
Routine check-ups and, in some cases, genetic testing can help identify predispositions to certain conditions early on. 'Roughly 40 percent of life expectancy can be traced through generations,' Dr. Nye says. 'If your grandparents and parents lived long, healthy lives, you've got a better shot.'
However, he cautions that genetic testing can also uncover unexpected information about family members, so it's essential to weigh the emotional and social implications.
Why It Matters Now?
Dr. Nye's advice lands at a time when life expectancy gains in many countries have started to plateau—or even decline. Obesity, sedentary lifestyles, and processed diets are contributing to this shift, despite years of progress in healthcare and medicine.
While the latest data may be disheartening, Dr. Nye's message is clear and empowering: longevity isn't just about luck. It's about small, sustained choices—choosing stairs over the elevator, frozen veggies over fast food, and bedtime over binge-watching. So next time you're stuck at your desk, remember—living to 100 might just start with standing up.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Alzheimer's disease: A blood test can detect early symptoms, finds study
Imagine getting tested for Alzheimer's with just a simple blood draw instead of going through complicated brain scans or spinal taps. Sounds like the future, right? Well, it's pretty much here. Researchers at the Mayo Clinic in the U.S. have been working on a new blood test that can accurately detect early signs of Alzheimer's disease, and the results are seriously impressive. This test looks at two specific proteins in your blood—amyloid beta 42/40 and p-tau217—both of which are linked to that gunky buildup in the brain called amyloid plaques, a telltale sign of Alzheimer's. So how accurate is it? Try 95% sensitivity, meaning it correctly identifies people who do have memory problems 95% of the time. That's pretty hard to beat. It also has 82% specificity, which means it's also really good at ruling out people who don't have Alzheimer's. What's even better? This isn't just lab testing. The study was done on over 500 real patients in a memory clinic—so it's based on actual, day-to-day medical situations, not just controlled experiments. Dr. Gregg Day, who led the study (published in Alzheimer's & Dementia journal), said this new blood test works just as well as the more invasive and expensive options we currently use. "It's about as accurate as spinal fluid testing," he told The Guardian, 'but way easier, less painful, and much cheaper.' In people who had Alzheimer's, the levels of p-tau217 were clearly higher compared to those who didn't, which helped the team confirm the diagnosis confidently. The best part? This blood test has already gotten the green light from the U.S. FDA—so it's not just theory anymore, it's actually available. 6 million Americans are living with Alzheimer's disease Alzheimer's disease is becoming a huge concern across the U.S.—and it's not just about forgetfulness in old age. It's a progressive brain disorder that slowly chips away at memory, thinking skills, and the ability to do everyday tasks. Right now, more than 6 million Americans are living with Alzheimer's, and that number is expected to nearly double by 2050. Most people with Alzheimer's are 65 or older, but it can also hit younger adults in what's called early-onset Alzheimer's. The biggest risk factor is age, but family history and genetics also play a role. The disease usually starts slow—maybe forgetting names or getting lost in familiar places—and worsens over time. The best part is science is catching up. New blood tests and brain imaging tools are helping doctors catch the disease earlier than ever before. There are also a few new medications out that might slow down the progression if taken early enough. Next up, researchers want to test it on even more diverse groups of people and also those who might be in the very early stages of Alzheimer's but don't have any symptoms yet. In short: diagnosing Alzheimer's just got a whole lot simpler—and that could change everything when it comes to early intervention and treatment. One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
12 hours ago
- Time of India
Want to boost brain health? Scientists recommed finding a person with THIS quality
Having someone who listens attentively may significantly boost cognitive resilience, according to a recent study. Researchers found that adults with readily available listeners demonstrated better cognitive function, even with age-related brain volume loss. This social support could potentially slow cognitive aging and delay Alzheimer's symptoms. Keeping the brain sharp is crucial for overall well-being. From cognition, memory, and emotional regulation, a healthy brain plays a key role in how we function daily. While we often turn to puzzles, exercise, and diet to maintain brain health, scientists now say something much simpler, yet often overlooked, could be just as powerful: having someone who listens! A study published in JAMA Network found a link between having someone you can count on to listen to you when you need to talk, with improved cognitive resilience. A person who is all ears According to the study, adults who have access to a good listener, a person who is available most or all of the time to provide emotional support, show significantly better cognitive resilience. This interaction will help the brain from declining, even with aging or diseases like Alzheimer's. 'We think of cognitive resilience as a buffer to the effects of brain aging and disease. This study adds to growing evidence that people can take steps, either for themselves or the people they care about most, to increase the odds they'll slow down cognitive aging or prevent the development of symptoms of Alzheimer's disease—something that is all the more important given that we still don't have a cure for the disease,' lead researcher Joel Salinas said. About 5 million people in America are living with Alzheimer's disease, a progressive condition that affects mostly those over 65. This condition interferes with memory, language, decision-making, and the ability to live independently. Salinas added that the results of this study indicate that people younger than 65 would benefit from social support. For every unit of brain volume loss, people in their 40s and 50s who had fewer listeners showed cognitive abilities similar to someone four years older than those who had more listeners. 'These four years can be incredibly precious. Too often, we think about how to protect our brain health when we're much older, after we've already lost a lot of time decades before to build and sustain brain-healthy habits. But today, right now, you can ask yourself if you truly have someone available to listen to you in a supportive way, and ask your loved ones the same. Taking that simple action sets the process in motion for you to ultimately have better odds of long-term brain health and the best quality of life you can have,' Salinas said. The study Researchers analyzed data from 2,171 participants in the Framingham Heart Study, one of the longest-running community-based studies in the U.S., with an average participant age of 63. The participants self-reported about the various types of social support they have, including access to someone who listens, offers good advice, and provides emotional support. The cognitive resilience of the participants was measured as the relative effect of total cerebral brain volume on global cognition, using MRI scans and neuropsychological assessments. Lower brain volumes tend to be associated with lower cognitive function. The researchers examined the modifying effect of individual forms of social support on the relationship between cerebral volume and cognitive performance. They found that the cognitive function of individuals with greater availability of one specific form of social support was higher relative to their total cerebral volume. This particular form of 'social support' was the availability of a listener, and it was linked with increased cognitive resilience. What you should do 'Loneliness is one of the many symptoms of depression, and has other health implications for patients. These kinds of questions about a person's social relationships and feelings of loneliness can tell you a lot about a patient's broader social circumstances, their future health, and how they're really doing outside of the clinic,' Salinas said. Researchers noted that further study is required for further understanding of the biological mechanisms that link psychosocial factors to brain health. 'While there is still a lot that we don't understand about the specific biological pathways between psychosocial factors like listener availability and brain health, this study gives clues about concrete, biological reasons why we should all seek good listeners and become better listeners ourselves,' Salinas concluded. One step to a healthier you—join Times Health+ Yoga and feel the change
Hans India
18 hours ago
- Hans India
Alzheimer's gene therapy shows promise to prevent brain damage
New Delhi: A novel gene therapy for Alzheimer's disease, which showed promise to protect the brain from damage and preserve cognitive function, has renewed hope for millions of patients with the neurodegenerative disease. Worldwide, approximately 57 million people live with dementia, and Alzheimer's disease is the most common cause, accounting for 60-70 per cent of cases. Alzheimer's occurs when abnormal proteins build up in the brain, leading to the death of brain cells and declines in cognitive function and memory. While current treatments can manage symptoms of Alzheimer's, the new gene therapy aims to halt or even reverse disease progression, said researchers from the University of California San Diego School of Medicine. They noted that, unlike existing treatments for Alzheimer's that target unhealthy protein deposits in the brain, the new approach could help address the root cause of Alzheimer's disease by influencing the behaviour of brain cells themselves. The study investigated the effect of hippocampal SynCav1 delivery in two distinct preclinical mice models. The results, published in the journal Signal Transduction and Targeted Therapy, showed that delivering the treatment at the symptomatic stage of the disease preserved hippocampal-dependent memory -- a critical aspect of cognitive function that is often impaired in Alzheimer's patients. Further, the finding stated that compared to healthy mice of the same age, the treated mice also had a similar pattern of gene expression. This suggests that the treatment has the potential to alter the behaviour of diseased cells to restore them to a healthier state. 'While multiple newly FDA-approved treatments focus on targeting amyloid-beta clearance in Alzheimer's patients, the therapeutic value of SynCav1 lies in its ability to protect vulnerable neurons and augment cellular responses -- mechanisms that differ from currently approved therapies,' said the researchers in the paper. Due to the multitude of neurotoxicity in the Alzheimer's brain, the team called for further studies to investigate SynCav1's therapeutic role when combined with amyloid-targeted drugs to enhance clinical outcomes.
